AUTHOR=Xu Jian , Li Shu-Zhen , Yin Min-Na , Liang Pei-Ling , Li Ping , Sun Ling
TITLE=Endometrial Preparation for Frozen–Thawed Embryo Transfer With or Without Pretreatment With GnRH Agonist: A Randomized Controlled Trial at Two Centers
JOURNAL=Frontiers in Endocrinology
VOLUME=12
YEAR=2021
URL=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.722253
DOI=10.3389/fendo.2021.722253
ISSN=1664-2392
ABSTRACT=ObjectiveThis prospective randomized controlled trial compared the reproductive outcomes of frozen embryo transfer (FET) with hormone replacement treatment (HRT) with or without gonadotropin-releasing hormone agonist (GnRHa) pretreatment.
MethodsA total of 133 patients scheduled for HRT-FET mainly because of tubal and/or male factors who received two high-quality cleavage-stage embryos were enrolled at two participating centers. The GnRHa group (n = 65) received GnRHa pretreatment, while the control group (n = 68) did not. Analysis was based on the intention-to-treat (ITT) principle.
ResultsAmong the 133 participants, 130 (97.7%) underwent embryo transfer and 127 (95.5%) completed the protocol. The clinical pregnancy rate according to ITT did not differ between the GnRHa and control groups [39/65 (60.0%) vs. 41/68 (60.3%), p = 0.887]. The implantation rate (47.6% vs. 45.3%, p = 0.713), early pregnancy loss rate (5.1% vs. 19.5%, p = 0.09), and live birth rate (49.2% vs. 50.0%, p = 0.920) were also comparable between groups.
ConclusionPretreatment with GnRHa does not improve the reproductive outcomes for women receiving HRT-FET.
Clinical Trial RegistrationThe study was registered with the Chinese Clinical Trial Registry (ChiCTR-IOR-17014170; http://www.chictr.org.cn).